Showing results (1-10 of 362) with videos related to
Sort By:
Pageof 37
Therapeutic Drug Monitoring|January 1, 1990
Area-under-the-curve monitoring of cyclosporine therapy: performance of different assay methods and their target concentrationsJ Grevel, K L Napoli, S Gibbons, et al.Molecular and Cellular Biochemistry|May 26, 1993
Generation of oxygen free radicals during the metabolism of cyclosporine A: a cause-effect relationship with metabolism inhibitionF Serino, J Grevel, K L Napoli, et al.Pharmaceutical Research|February 1, 1991
Prediction of acute graft rejection in renal transplantation: the utility of cyclosporine blood concentrationsJ Grevel, K L Napoli, M S Welsh, et al.Therapeutic Drug Monitoring|March 1, 1991
Area under the curve monitoring of cyclosporine therapy: the early posttransplant periodJ Grevel, B D KahanTransplantation|November 1, 1988
Optimization of cyclosporine therapy in renal transplantation by a pharmacokinetic strategyB D Kahan, J GrevelClinical Chemistry|November 1, 1991
Abbreviated kinetic profiles in area-under-the-curve monitoring of cyclosporine therapyJ Grevel, B D KahanJournal of Chromatography. B, Biomedical Applications|March 18, 1994
Sample clean-up and high-performance liquid chromatographic techniques for measurement of whole blood rapamycin concentrationsK L Napoli, B D KahanClinical Chemistry|December 1, 1996
Routine clinical monitoring of sirolimus (rapamycin) whole-blood concentrations by HPLC with ultraviolet detectionK L Napoli, B D KahanTransplantation Proceedings|June 1, 1990
Nonselective measurement of cyclosporine for therapeutic drug monitoring by fluorescence polarization immunoassay with a rabbit polyclonal antibody: I. Evaluation of the serum methodology and comparison with a sheep polyclonal antibody in an 3H-tracer mediated radioimmunoassayK L Napoli, B D KahanClinics in Laboratory Medicine|September 1, 1991
Considerations for monitoring cyclosporine in transplant recipientsK L Napoli, B D KahanPageof 37